- ThinkEquity upgraded InterMune (ITMN) to buy from hold following the FDA advisory committee's approval of Esbriet. InterMune was also upgraded to outperform from market perform at Wells Fargo.
- Piper Jaffray upgraded Radian (RDN) to neutral from underweight with a $9 target. The firm believes the company will not have to raise capital as the government is allowing it to increase its leverage ratio beyond historic maximum levels.
- JPMorgan upgraded ExlService (EXLS) to neutral from underweight following the company's Q4 results.
- Lockheed Martin (LMT) was upgraded to neutral from underperform at Macquarie.
- Analog Devices (ADI) was upgraded to outperform from market perform at Bernstein.
- Goodrich (GR) was upgraded to conviction buy from buy at Goldman.
WGL posts
FeedAnalyst Calls: ADI, BCS, CMA, CVX, FACT, GR, ITMN, JCG, LMT, NFLX ...
Continue reading Analyst Calls: ADI, BCS, CMA, CVX, FACT, GR, ITMN, JCG, LMT, NFLX ...
What Happened When Alex Kenjeev Paid His Student Loan in Cash
America's 10 Highest-Paid CEOs of 2011 (and How They Earned It)


